Augmentation of seizure induction in electroconvulsive therapy: A clinical reappraisal

Journal of ECT

Volumn 18, Issue 3, 2002, Pages 118-125

  Datto, Catherine ^a   Rai, Anil K ^a   Ilivicky, Howard J ^a   Caroff, Stanley N ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Caffeine; Electroconvulsive therapy; Etomidate; Hyperventilation; Ketamine; Proconvulsant agents; Seizures; Theophylline

Indexed keywords

AMFEBUTAMONE; AMINOPHYLLINE; AMPHETAMINE; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; CAFFEINE; CLOZAPINE; CONVULSANT AGENT; ETOMIDATE; FLUOXETINE; KETAMINE; LABETALOL; LITHIUM; LOXAPINE; METHOHEXITAL; METHYLXANTHINE; PAROXETINE; PENTETRAZOLE; PLACEBO; PROPOFOL; PSYCHOTROPIC AGENT; THEOPHYLLINE; THIOPENTAL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY NEUROSIS; ARTICLE; ATAXIA; CLINICAL TRIAL; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION; HEART ARRHYTHMIA; HUMAN; HYPERVENTILATION; INJECTION PAIN; MEDLINE; MYOCLONUS; NAUSEA; SCHIZOPHRENIA; SEIZURE; SEIZURE THRESHOLD; TREATMENT OUTCOME; TREMOR;

ANESTHETICS; CAFFEINE; ELECTROCONVULSIVE THERAPY; HUMANS; OXYGEN; PSYCHOTROPIC DRUGS; THEOPHYLLINE;

EID: 0036401574     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200209000-00002     Document Type: Article

References (105)

1. Ottoson JO. Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatrica Scand (Suppl) 1960;145:1-141.
2. Fink M. Convulsive Therapy: Theory and Practice. New York: Raven Press, 1979.
3. NIH Consensus Conference. Electroconvulsive therapy. JAMA 1985;254:2103-8.
4. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. Washington, DC: American Psychiatric Press Inc, 2001.
5. Lalla FR, Milroy T. The current status of seizure duration in the practice of electroconvulsive therapy. Can J Psychiatry 1996;41:299-304.
6. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991;14:803-43.
7. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New Engl J Med 1993;328:839-46.
8. Sackeim HA. Central issues regarding the mechanisms of action of electroconvulsive therapy: directions for future research. Psychopharmacol Bull 1994;30:281-308.
9. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-34.
10. Coffey CE, Lucke J, Weiner RD, et al. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry 1995;37:713-20.
11. McCall WV, Reboussin DM, Weiner RD, et al. Titrated moderately suprathreshold versus fixed high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 2000;57:438-44.
12. Weiner RD, Coffey E, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am 1991;14:845-69.
13. Abrams R. ECT stimulus parameters as determinants of seizure quality. Psychiatric Annals 1996;26:701-4.
14. Krystal AD, Dean MD, Weiner RD, et al. ECT stimulus intensity; are present ECT devices too limited? Am J Psychiatry 2000;157:963-7.
15. Abrams R. Electroconvulsive therapy requires higher dosage levels: Food and Drug Administration action is required. Arch Gen Psychiatry 2000;57:445-6.
16. Swartz CM. Age effects on electroconvulsive therapy seizure resistance. Convuls Ther 1993;9:181-4.
17. Zorumski CF, Rubin EH, Burke WJ. Electroconvulsive therapy for the elderly: a review. Hosp Communit Psychiatry 1988;39:643-7.
18. Frey R, Heiden A, Scharfetter J, et al. Inverse relation between stimulus intensity and seizure duration: implications for ECT procedure. J ECT 2001;17:102-8.
19. Nobler MS, Sackeim HA. Augmentation strategies in electroconvulsive therapy: a synthesis. Convuls Ther 1993;9:331-51.
20. Bailey KC. Use of amphetamine sulphas in facilitating electrically induced convulsions. BMJ 1943;1:250-3.
21. Swartz CM. A summary of methods to potentiate ECT seizures. Psychiatric Annals 1996;26:721.
22. Shapira B, Zohar J, Newman M, et al. Potentiation of seizure length and clinical response to ECT by caffeine pretreatment; a case report. Convuls Ther 1985;1:58-60.
23. Shapira B, Lerer B, Gilboa D, et al. Facilitation of ECT by caffeine pretreatment. Am J Psychiatry 1987;144:1199-202.
24. Hinkle PE, Coffey CE, Weiner RD, et al. Use of caffeine to lengthen seizures in ECT. Am J Psychiatry 1987;144:1143-8.
25. Coffey CE, Weiner RD, Hinkle PE, et al. Augmentation of ECT seizures with caffeine. Biol Psychiatry 1987;22:637-49.
26. Coffey CE, Figiel GS, Weiner RD, et al. Caffeine augmentation of ECT. Am J Psychiatry 1990;147:579-85.
27. Calev A, Fink M, Petrides G, et al. Caffeine pretreatment enhances clinical efficacy and reduces cognitive effects of electroconvulsive therapy. Convuls Ther 1993;9:95-100.
28. McCall WV, Reid S, Rosenquist P, et al. A reappraisal of the role of caffeine in ECT. Am J Psychiatry 1993;150:1543-5.
29. Rosenquist PB, McCall WV, Farah A, et al. Effects of caffeine pretreatment on measures of seizure impact. Convuls Ther 1994;10:181-5.
30. Ancill RJ, Carlyle W. Oral caffeine augmentation of ECT. Am J Psychiatry 1992;149:137.
31. Jaffe R, Dubin WR. Oral versus intravenous caffeine augmentation of ECT. Am J Psychiatry 1992;149:1610.
32. Acevedo AG, Smith JK. Adverse reaction to use of caffeine in ECT. Am J Psychiatry 1988;145:529-30.
33. Kellner CH, Batterson R. Low-dose caffeine in ECT. Convuls Ther 1989;5:189-90.
34. Lurie SN, Coffey CE. Caffeine-modified electroconvulsive therapy in depressed patients with medical illness. J Clin Psychiatry 1990;51:154-7.
35. Jaffe R, Britishubaker G, Dubin WR, et al. Caffeine-associated cardiac dysrhythmia during ECT: report of three cases. Convuls Ther 1990;6:308-13.
36. Kelsey MC, Grossberg GT. Safety and efficacy of caffeine-augmented ECT in elderly depressives: a retrospective study. J Geriatr Psychiatry Neurol 1995;8:168-72.
37. Kellner CH, Bachman DL. Olfactory hallucination after intravenous caffeine. Am J Psychiatry 1992;149:422.
38. Swartz CM, Lewis RK. Theophylline reversal of electroconvulsive therapy (ECT) seizure inhibition. Psychosomatics 1991;32:47-51.
39. Stewart JT. Prolongation of ECT-induced seizures with theophylline. J Am Geriatr Soc 1996;44:475.
40. Leentjens AFG, van den Broek WW, Kusuma A, et al. Facilitation of ECT by intravenous administration of theophylline. Convuls Ther 1997;12:232-7.
41. Stern L, Dannon PN, Hirschman S, et al. Aminophylline increases seizure length during electroconvulsive therapy. J ECT 1999;15:252-7.
42. Girish K, Jayaprakash MS, Gangadhar BN, et al. Etophylline as a proconvulsant. Convuls Ther 1996;12:196-8.
43. Peters SG, Wochos DN, Peterson GC. Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy. Mayo Clin Proc 1984;59:568-70.
44. Devanand DP, Decina P, Sackeim HA, et al. Status epilepticus following ECT in a patient receiving theophylline. J Clin Psychopharmcol 1988;8:153.
45. Rasmussen KG, Zorumski CF. Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry 1993;54:427-31.
46. Swartz CM. Anesthesia for ECT. Convuls Ther 1993;9:301-16.
47. Bergsholm P, Swartz CM. Anesthesia in electroconvulsive therapy and alternatives to barbiturates. Psychiatr Ann 1996;26:709-12.
48. Nettelbladt P. Factors influencing number of treatments and seizure duration in ECT: drug treatment, social class. Convuls Ther 1988;4:160-8.
49. Geretssegger C, Rochowanski E, Kartnig C, et al. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs. J ECT 1998;14:28-35.
50. Martin BA, Cooper RM, Parikh SV. Propofol anesthesia, seizure duration and ECT: a case report and literature review. J ECT 1998;14:99-108.
51. Crispin PA, Crommen AM. A progression in electroconvulsive therapy: the non-barbiturate anesthetic drug etomidate. Acta Psychiatr Belg 1976;76:678-87.
52. O'Carroll TM, Blogg CE, Hoinville EA, et al. Etomidate in electroconvulsive therapy: a within patient comparison with alphaxalone/alphadalone. Anesthesia 1977;32:868-72.
53. Christensen P, Kragh-Sorensen P, Sorensen C, et al. EEG-monitored ECT: a comparison of seizure duration under anesthesia with etomidate and thiopentone. Convuls Ther 1986;2:145-50.
54. Trzepacz PT, Weniger FC, Greenhouse J. Etomidate anesthesia increases seizure duration during ECT. A retrospective study. Gen Hosp Psychiatry 1993;15:115-20.
55. Saffer S, Berk M. Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopental. J ECT 1998;14:89-93.
56. Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 1995;81:596-602.
57. Ilivicky H, Caroff SN, Simone AF. Etomidate during ECT for elderly seizure-resistant patients. Am J Psychiatry 1995;152:957-8.
58. Gran L, Bergsholm P, Bleie H. Seizure duration in unilateral electroconvulsive therapy. A comparison of the anesthetic agents etomidate and althesin with methohexitone. Acta Psychiatr Scand 1984;69:472-83.
59. Greenberg L, Boccio R, Fink M. A comparison of etomidate and methohexital anesthesia for electroconvulsive therapy. Ann Clin Psychiatry 1989;1:39-42.
60. Kovac AL, Pardo M. A comparison between etomidate and methohexital for anesthesia in ECT. Convuls Ther 1992;8:118-25.
61. Dean MD, Krystal AD, Weiner RD, et al. Ketamine anesthesia augments ECT seizure duration. In: New research abstracts, American Psychiatric Association Annual Meetings; May 30-June 4, 1998; Toronto, Ontario. Abstract NR 35.
62. Rasmussen KG, Jarvis MR, Zorumski CF. Ketamine anesthesia in electroconvulsive therapy. Convuls Ther 1997;12:217-23.
63. McInnes EC, James NM. A comparison of ketamine and methohexital in electroconvulsive therapy. Med J Aust 1972;1:1031-2.
64. Brewer CL, Davidson JRT, Hereward S. Ketamine ('Ketlar'): a safer anesthetic for ECT. Br J Psychiatry 1972;120:679-80.
65. Slover R, Assil K, Giese A, et al. Substitution of alfentanil for Brevital increases seizure duration for electroconvulsive therapy. Anesth Analg 1993;76:S404.
66. Dinwiddie SH, Isenberg KE. Combined alfentanil-methohexital anesthesia in electroconvulsive therapy. Convuls Ther 1995;11:170-6.
67. Nguyen TT, Chhibber AK, Lustik SJ, et al. Effect of methohexitone and propofol with or without alfentanil on seizure duration and recovery in electroconvulsive therapy. Br J Anaesth 1997;79:801-3.
68. Rasanen J, Martin DJ, Downs JB, et al. Oxygen supplementation during electroconvulsive therapy. Br J Anaesth 1988;61:593-7.
69. Holmberg G. The factor of hypoxemia in electroshock therapy. Am J Psychiatry 1953;110:115-8.
70. Lew JKL, Eastley RJ, Hanning CD. Oxygenation during electroconvulsive therapy: a comparison of two anesthetic techniques. Anesthesia 1986;41:1092-7.
71. Swindells SR, Simpson KH. Oxygen saturation during electroconvulsive therapy. Br J Psychiatry 1987;150:695-7.
72. Bergsholm P, Gran L, Bleie H. Seizure duration in unilateral electroconvulsive therapy. The effect of hypocapnia induced by hyperventilation and the effect of ventilation with oxygen. Acta Psychiatr Scand 1984;69:121-8.
73. Chater SN, Simpson KH. Effect of passive hyperventilation on seizure duration in patients undergoing electroconvulsive therapy. Br J Anaesth 1988;60:70-3.
74. Fink M, Kellner CH. ECT and drugs: concurrent administration. Convuls Ther 1993;9:237-40.
75. Klapheke MM. Combining ECT and antipsychotic agents: benefits and risks. Convuls Ther 1993;9:241-55.
76. Pritchett JT, Bernstein HJ, Kellner CH. Combined ECT and antidepressant drug therapy. Convuls Ther 1993;9:256-61.
77. Small JG, Milstein V, Klapper M, et al. ECT combined with neuroleptics in the treatment of schizophrenia. Psychopharmacol Bull 1982;18:34-5.
78. Fink M. ECT and clozapine in schizophrenia. J ECT 1998;14:223-6.
79. Kupchik M, Spivak B, Mester R, et al. Combined electroconvulsiveclozapine therapy. Clin Neuropharmacol 2000;23:14-6.
80. Beale MD, Pritchett JT, Kellner CH. Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine. Convuls Ther 1994;10:228-31.
81. Landy DA. Combined use of clozapine and ECT. Convuls Ther 1991;7:218-21.
82. Cardwell BA, Nakai B. Seizure activity in combined clozapine and ECT: a retrospective view. Convuls Ther 1995;11:110-3.
83. Poyurusky M, Weizman A. Safety and effectiveness of combined ECT and clozapine in treatment-resistant mania. Eur Psychiatry 1996;11:319-21.
84. Bloch Y, Mor I, Pollack M. Should the administration of ECT during clozapine therapy be contraindicated? Br J Psychiatry 1996;169:253-4.
85. Lurie SC. Combined use of ECT and clozapine. J Clin Psychiatry 1996;57:94-5.
86. Frankenburg FR, Suppes T, McLean PE. Combined clozapine and electroconvulsive therapy. Convuls Ther 193;9:176-80.
87. Masiar SJ, Johns CA. ECT following clozapine. Br J Psychiatry 1991;158:135-6.
88. Husni M, Haggarty J, Peat C. Clozapine does not increase ECT-seizure duration. Can J Psychiatry 1999;44:190-1.
89. Nelson JP, Benjamin L. Efficacy and safety of combined ECT and tricyclic antidepressant drugs in the treatment of depressed geriatric patients. Convuls Ther 1989;5:321-9.
90. Lauritzen L, Odgaard K, Clemmens L, et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996;94:241-51.
91. Caracci G, Decina P. Fluoxetine and prolonged seizure. Convuls Ther 1991;7:145-7.
92. Serfaty M, Martin LM, Lingham R, et al. The effect of psychotropic medication on seizure duration during bilateral electroconvulsive therapy: a retrospective study. J Psychopharmacol 1996;10:303-8.
93. Tobiansky I, Lloyd G. ECT seizure threshold and fluoxetine. Br J Psychiatry 1995;166:263.
94. Gutierrez-Estinou R, Pope HG. Does fluoxetine prolong electrically induced seizures? Convuls Ther 1989;5:344-8.
95. Kellner CH, Bruno RN. Fluoxetine and ECT. Convuls Ther 1989;5:367-8.
96. Zis AP. Acute administration of fluoxetine and the duration of electrically induced seizures. Convuls Ther 1992;8:38-53.
97. Harsh HH, Haddox JD. Electroconvulsive therapy and fluoxetine. Convuls Ther 1990;6:250-1.
98. Curran S. Effects of paroxetine on seizure length during electroconvulsive therapy. Acta Psychiatr Scand 1995;92:239-40.
99. Popakostas YG, Markianos M, Zervas IM, et al. Administration of citalopram before ECT: seizure duration and hormone responses. J ECT 2000;16:356-60.
100. Lanes T, Ravaris CL. Prolonged ECT seizure duration in a patient taking trazodone. Am J Psychiatry 1993;150:525.
101. Kaufman KR, Finstead BA, Kaufman ER. Status epilepticus following electroconvulsive therapy. Mt Sinai J Med 1986;53:119-22.
102. Bernardo M, Navarro V, Salva J, et al. Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study. J ECT 2000;16:38-42.
103. Conway CR, Nelson LA. The combined use of bupropion, lithium and venlafaxine during ECT: a case of prolonged seizure activity. J ECT 2001;17:216-8.
104. Fiegel GS, Jarvis MR. Electroconvulsive therapy in a depressed patient receiving bupropion. J Clin Psychopharmacol 1990;10:376.
105. Kellner CH, Pritchett JT, Jackson CW. Bupropion coadministration with electroconvulsive therapy: two case reports. J Clin Psychopharmacol 1994;14:215-6.